Literature DB >> 19790801

Adverse drug reactions.

.   

Abstract

There are many methods of surveillance of new drugs for adverse reactions once they have been fully marketed. The yellow card system run by the Committee on Safety of Medicines is not well used by doctors: perhaps there is some other way of reporting adverse reactions?

Year:  1991        PMID： 19790801      PMCID： PMC2560336     

Source DB:  PubMed          Journal:  Occas Pap R Coll Gen Pract        ISSN： 1352-2450


  9 in total

1.  Did the drug do it?

Authors:  M J Langman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

Review 2.  Adverse drug interactions.

Authors:  M J Brodie; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

3.  Post-marketing surveillance of enalapril.

Authors: 
Journal:  J R Coll Gen Pract       Date:  1987-11

Review 4.  New drugs. Adverse reactions. I.

Authors:  D N Bateman; S Chaplin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

5.  Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.

Authors:  W H Inman; N S Rawson; L V Wilton; G L Pearce; C J Speirs
Journal:  BMJ       Date:  1988-10-01

6.  Patients as a direct source of information on adverse drug reactions.

Authors:  A S Mitchell; D A Henry; R Sanson-Fisher; D L O'Connell
Journal:  BMJ       Date:  1988-10-08

7.  Benoxaprofen--adverse reactions and monitoring in general practice.

Authors:  P G Newrick; D Bainton
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

8.  Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice.

Authors:  W D Cooper; D Sheldon; D Brown; G R Kimber; V L Isitt; W J Currie
Journal:  J R Coll Gen Pract       Date:  1987-08

9.  Involving the patient in reporting adverse drug reactions.

Authors:  J P Campbell; J G Howie
Journal:  J R Coll Gen Pract       Date:  1988-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.